Literature DB >> 35913504

[ORATOR2 trial: randomized comparison of primary surgery vs. primary radiotherapy for HPV-associated oropharyngeal cancer in the context of de-escalated therapy].

Alexander Fabian1,2, Nils H Nicolay3, David Krug4.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35913504      PMCID： PMC9581808          DOI： 10.1007/s00066-022-01987-2

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   4.033


× No keyword cloud information.
  11 in total

1.  [Radiotherapy versus transoral robotic surgery for primary treatment of oropharyngeal squamous cell carcinoma: randomisation decides].

Authors:  Alexander Fabian; David Krug
Journal:  Strahlenther Onkol       Date:  2020-02       Impact factor: 3.621

Review 2.  Transoral Endoscopic Head and Neck Surgery and Its Role Within the Multidisciplinary Treatment Paradigm of Oropharynx Cancer: Robotics, Lasers, and Clinical Trials.

Authors:  F Christopher Holsinger; Robert L Ferris
Journal:  J Clin Oncol       Date:  2015-09-08       Impact factor: 44.544

3.  Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial.

Authors:  Anthony C Nichols; Julie Theurer; Eitan Prisman; Nancy Read; Eric Berthelet; Eric Tran; Kevin Fung; John R de Almeida; Andrew Bayley; David P Goldstein; Michael Hier; Khalil Sultanem; Keith Richardson; Alex Mlynarek; Suren Krishnan; Hien Le; John Yoo; S Danielle MacNeil; Eric Winquist; J Alex Hammond; Varagur Venkatesan; Sara Kuruvilla; Andrew Warner; Sylvia Mitchell; Jeff Chen; Martin Corsten; Stephanie Johnson-Obaseki; Libni Eapen; Michael Odell; Christina Parker; Bret Wehrli; Keith Kwan; David A Palma
Journal:  Lancet Oncol       Date:  2019-08-12       Impact factor: 41.316

4.  Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial.

Authors:  Anthony C Nichols; Julie Theurer; Eitan Prisman; Nancy Read; Eric Berthelet; Eric Tran; Kevin Fung; John R de Almeida; Andrew Bayley; David P Goldstein; Michael Hier; Khalil Sultanem; Keith Richardson; Alex Mlynarek; Suren Krishnan; Hien Le; John Yoo; S Danielle MacNeil; Eric Winquist; J Alex Hammond; Varagur Venkatesan; Sara Kuruvilla; Andrew Warner; Sylvia Mitchell; Jeff Chen; Martin Corsten; Stephanie Johnson-Obaseki; Michael Odell; Christina Parker; Bret Wehrli; Keith Kwan; David A Palma
Journal:  J Clin Oncol       Date:  2022-01-07       Impact factor: 44.544

5.  Transoral robotic surgery adoption and safety in treatment of oropharyngeal cancers.

Authors:  Jamie R Oliver; Michael J Persky; Binhuan Wang; Umamaheswar Duvvuri; Neil D Gross; Alec E Vaezi; Luc G T Morris; Babak Givi
Journal:  Cancer       Date:  2021-11-11       Impact factor: 6.921

Review 6.  Optimizing Treatment De-Escalation in Head and Neck Cancer: Current and Future Perspectives.

Authors:  Ari J Rosenberg; Everett E Vokes
Journal:  Oncologist       Date:  2020-09-21

7.  Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311).

Authors:  Robert L Ferris; Yael Flamand; Gregory S Weinstein; Shuli Li; Harry Quon; Ranee Mehra; Joaquin J Garcia; Christine H Chung; Maura L Gillison; Umamaheswar Duvvuri; Bert W O'Malley; Enver Ozer; Giovana R Thomas; Wayne M Koch; Neil D Gross; R Bryan Bell; Nabil F Saba; Miriam Lango; Eduardo Méndez; Barbara Burtness
Journal:  J Clin Oncol       Date:  2021-10-26       Impact factor: 50.717

8.  Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial.

Authors:  Anthony C Nichols; Pencilla Lang; Eitan Prisman; Eric Berthelet; Eric Tran; Sarah Hamilton; Jonn Wu; Kevin Fung; John R de Almeida; Andrew Bayley; David P Goldstein; Antoine Eskander; Zain Husain; Houda Bahig; Apostolos Christopoulous; Michael Hier; Khalil Sultanem; Keith Richardson; Alex Mlynarek; Suren Krishnan; Hien Le; John Yoo; S Danielle MacNeil; Adrian Mendez; Eric Winquist; Nancy Read; Varagur Venkatesan; Sara Kuruvilla; Andrew Warner; Sylvia Mitchell; Martin Corsten; Murali Rajaraman; Stephanie Johnson-Obaseki; Libni Eapen; Michael Odell; Shamir Chandarana; Robyn Banerjee; Joseph Dort; T Wayne Matthews; Robert Hart; Paul Kerr; Samuel Dowthwaite; Michael Gupta; Han Zhang; Jim Wright; Christina Parker; Bret Wehrli; Keith Kwan; Julie Theurer; David A Palma
Journal:  BMC Cancer       Date:  2020-02-14       Impact factor: 4.430

9.  Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002).

Authors:  Sue S Yom; Pedro Torres-Saavedra; Jimmy J Caudell; John N Waldron; Maura L Gillison; Ping Xia; Minh T Truong; Christina Kong; Richard Jordan; Rathan M Subramaniam; Min Yao; Christine H Chung; Jessica L Geiger; Jason W Chan; Brian O'Sullivan; Dukagjin M Blakaj; Loren K Mell; Wade L Thorstad; Christopher U Jones; Robyn N Banerjee; Christopher Lominska; Quynh-Thu Le
Journal:  J Clin Oncol       Date:  2021-01-28       Impact factor: 44.544

Review 10.  De-Escalation Strategies of (Chemo)Radiation for Head-and-Neck Squamous Cell Cancers-HPV and Beyond.

Authors:  Alexander Rühle; Anca-Ligia Grosu; Nils H Nicolay
Journal:  Cancers (Basel)       Date:  2021-05-04       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.